Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Liver Diseases

  Free Subscription


4 AJR Am J Roentgenol
3 Biochem Biophys Res Commun
1 BMC Gastroenterol
1 Cancer
2 Eur Radiol
2 Gut
4 Hepatology
1 Int J Cancer
1 J Gastroenterol Hepatol
8 J Hepatol
2 PLoS One
2 Radiology
1 Transplant Proc
1 Transplantation

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

    Editorial Comment: Increased liver lesion visualization on CT without increased cost.
    AJR Am J Roentgenol. 2022 Feb 2. doi: 10.2214/AJR.22.27391.

    Editorial Comment: Factors Impacting Ultrasound LI-RADS Visualization Scores-Optimizing Future Quality Assurance and Standards.
    AJR Am J Roentgenol. 2022;218:1020.

  3. BONGERS MN, Walter S, Fritz J, Bier G, et al
    Interindividual Comparison of Frequency-Selective Nonlinear Blending to Conventional CT for Detection of Focal Liver Lesions Using MRI as the Reference Standard.
    AJR Am J Roentgenol. 2022 Jan 12. doi: 10.2214/AJR.21.26922.
    PubMed         Abstract available

  4. FETZER DT, Browning T, Xi Y, Yokoo T, et al
    Associations of Ultrasound LI-RADS Visualization Score With Examination-, Sonographer-, and Radiologist-Factors: Retrospective Assessment in Over 10,000 Examinations.
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.26735.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  5. HONG W, Peng X, Zhou X, Li P, et al
    FXR/ASS1 axis attenuates the TAA-induced liver injury through arginine metabolism.
    Biochem Biophys Res Commun. 2022;611:31-37.
    PubMed         Abstract available

  6. YOKOBORI K, Gruzdev A, Negishi M
    Mice blocking Ser347 phosphorylation of pregnane x receptor develop hepatic fasting-induced steatosis and hypertriglyceridemia.
    Biochem Biophys Res Commun. 2022;615:75-80.
    PubMed         Abstract available

  7. WEN H, He R, Wang H, Zhao S, et al
    Effects of small molecule inhibitor SW033291 on hepatic ischemia-reperfusion injury in mice.
    Biochem Biophys Res Commun. 2022;615:70-74.
    PubMed         Abstract available

    BMC Gastroenterol

  8. MAI RY, Bai T, Luo XL, Wu GB, et al
    Preoperative fibrinogen-to-albumin ratio predicts the prognosis of patients with hepatocellular carcinoma subjected to hepatectomy.
    BMC Gastroenterol. 2022;22:261.
    PubMed         Abstract available


  9. LEBECK LEE CM, Ziogas IA, Agarwal R, Alexopoulos SP, et al
    A contemporary systematic review on liver transplantation for unresectable liver metastases of colorectal cancer.
    Cancer. 2022 Mar 14. doi: 10.1002/cncr.34170.
    PubMed         Abstract available

    Eur Radiol

  10. DE COBELLI F, Calandri M, Della Corte A, Sirovich R, et al
    Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.
    Eur Radiol. 2022;32:4147-4159.
    PubMed         Abstract available

  11. ZHANG K, Xie SS, Li WC, Ye ZX, et al
    Prediction of microvascular invasion in HCC by a scoring model combining Gd-EOB-DTPA MRI and biochemical indicators.
    Eur Radiol. 2022;32:4186-4197.
    PubMed         Abstract available


  12. MARCHI E, Ramamurthy N, Ansari MA, Harrer CE, et al
    Defining the key intrahepatic gene networks in HCV infection driven by sex.
    Gut. 2022 May 25. pii: gutjnl-2021-326314. doi: 10.1136/gutjnl-2021-326314.
    PubMed         Abstract available

  13. DHAR A, Haboubi HN, Attwood SE, Auth MKH, et al
    British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults.
    Gut. 2022 May 23. pii: gutjnl-2022-327326. doi: 10.1136/gutjnl-2022-327326.
    PubMed         Abstract available


  14. LI L, Zhang Y, Zhou Y, Hu H, et al
    Quaternary Nanoparticles Enable Sustained Release of Bortezomib for Hepatocellular Carcinoma.
    Hepatology. 2022 May 21. doi: 10.1002/hep.32584.
    PubMed         Abstract available

  15. JALAN-SAKRIKAR N, Brevini T, Huebert RC, Sampaziotis F, et al
    Organoids and Regenerative Hepatology.
    Hepatology. 2022 May 21. doi: 10.1002/hep.32583.
    PubMed         Abstract available

  16. KIMURA Y, Koyama Y, Taura K, Kudoh A, et al
    Characterization and role of collagen gene expressing hepatic cells following partial hepatectomy in mice.
    Hepatology. 2022 May 23. doi: 10.1002/hep.32586.
    PubMed         Abstract available

  17. ZHANG JW, Fang J, Xun Z, Xu Y, et al
    Letter to the Editor: Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in the Real World.
    Hepatology. 2022 May 23. doi: 10.1002/hep.32588.

    Int J Cancer

  18. WEN Q, Chan KH, Shi K, Lv J, et al
    Tobacco smoking and solid fuels for cooking and risk of liver cancer: A prospective cohort study of 0.5 million Chinese adults.
    Int J Cancer. 2022;151:181-190.
    PubMed         Abstract available

    J Gastroenterol Hepatol

  19. DUNN W, Song X, Koestler D, Grdinovac K, et al
    Patients with type 2 diabetes and elevated fibrosis-4 are under-referred to hepatology and have unrecognized hepatic decompensation.
    J Gastroenterol Hepatol. 2022 May 25. doi: 10.1111/jgh.15900.
    PubMed         Abstract available

    J Hepatol

  20. SEMMLER G, Mandorfer M
    Substantiating evidence for HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease.
    J Hepatol. 2022 May 5. pii: S0168-8278(22)00267.

  21. DE FRANCHIS R, Bosch J, Garcia-Tsao G, Reiberger T, et al
    Reply to: 'Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma'.
    J Hepatol. 2022 May 5. pii: S0168-8278(22)00265.

  22. HUSAIN A, Chiu YT, Oi-Lin Ng I
    EFNAs are functional predictors for overall survival of hepatocellular carcinoma patients.
    J Hepatol. 2022 May 20. pii: S0168-8278(22)00317.

  23. CHU CM, Liaw YF
    Hepatocyte expression of hepatitis B surface and core antigens across phases of chronic hepatitis B infection.
    J Hepatol. 2022 May 20. pii: S0168-8278(22)00324.

  24. RATZIU V, Francque S, Sanyal A
    Breakthroughs in therapies for NASH and remaining challenges.
    J Hepatol. 2022;76:1263-1278.
    PubMed         Abstract available

  25. GE J, Kim WR, Lai JC, Kwong AJ, et al
    "Beyond MELD" - Emerging strategies and technologies for improving mortality prediction, organ allocation and outcomes in liver transplantation.
    J Hepatol. 2022;76:1318-1329.
    PubMed         Abstract available

  26. BAJAJ JS, Ng SC, Schnabl B
    Promises of microbiome-based therapies.
    J Hepatol. 2022;76:1379-1391.
    PubMed         Abstract available

  27. GARDIN A, Remih K, Gonzales E, Andersson ER, et al
    Modern therapeutic approaches to liver-related disorders.
    J Hepatol. 2022;76:1392-1409.
    PubMed         Abstract available

    PLoS One

  28. MUCKE VT, Peiffer KH, Kessel J, Schwarzkopf KM, et al
    Impact of colonization with multidrug-resistant organisms on antibiotic prophylaxis in patients with cirrhosis and variceal bleeding.
    PLoS One. 2022;17:e0268638.
    PubMed         Abstract available

  29. ZHANG XF, Lai L, Zhou H, Mo YJ, et al
    Stereotactic body radiotherapy plus transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma patients with portal vein tumour thrombus: A meta-analysis.
    PLoS One. 2022;17:e0268779.
    PubMed         Abstract available


  30. GAO RZ, Sun WB, Gao J
    Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: Is It a Promising Treatment for Giant Liver Hemangioma?
    Radiology. 2022;303:E39.

  31. RONOT M
    Performance of LI-RADS for the Noninvasive Diagnosis of HCC: Pathology Should Not Be the Only Acceptable Reference.
    Radiology. 2022;303:546-547.

    Transplant Proc

  32. SILVA NA, Waisberg DR, Fernandes MR, Pinheiro RS, et al
    Incidence of Donor Hepatic Artery Thrombosis in Liver Grafts Recognized During Organ Procurement and Backtable: A Rare but Treacherous Pitfall In Liver Transplantation.
    Transplant Proc. 2022 May 19. pii: S0041-1345(22)00268.
    PubMed         Abstract available


  33. DAVE S, Yang K, Schnickel GT, Kono Y, et al
    The Impact of Treatment of Hepatocellular Carcinoma With Immune Checkpoint Inhibitors on Pre- and Post-liver Transplant Outcomes.
    Transplantation. 2022;106:e308-e309.

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.